Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
2006-9-4
pubmed:abstractText
Nuclear Factor kappa B (NFkappaB) is a eukaryotic transcription factor that is constitutively active in human cancers and can be inhibited by the naturally occurring sesquiterpene lactone, parthenolide (P).
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Anilides, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Bridged Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2, http://linkedlifedata.com/resource/pubmed/chemical/JNK Mitogen-Activated Protein..., http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B, http://linkedlifedata.com/resource/pubmed/chemical/Nitriles, http://linkedlifedata.com/resource/pubmed/chemical/Sesquiterpenes, http://linkedlifedata.com/resource/pubmed/chemical/TNF Receptor-Associated Factor 1, http://linkedlifedata.com/resource/pubmed/chemical/TNF Receptor-Associated Factor 2, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/Tosyl Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/bicalutamide, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel, http://linkedlifedata.com/resource/pubmed/chemical/parthenolide, http://linkedlifedata.com/resource/pubmed/chemical/taxane
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0270-4137
pubmed:author
pubmed:copyrightInfo
(c) 2006 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1498-511
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16921510-Androgen Antagonists, pubmed-meshheading:16921510-Anilides, pubmed-meshheading:16921510-Animals, pubmed-meshheading:16921510-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:16921510-Antineoplastic Agents, Phytogenic, pubmed-meshheading:16921510-Bridged Compounds, pubmed-meshheading:16921510-Cell Line, Tumor, pubmed-meshheading:16921510-Drug Synergism, pubmed-meshheading:16921510-Endothelium, Vascular, pubmed-meshheading:16921510-Fibroblast Growth Factor 2, pubmed-meshheading:16921510-Humans, pubmed-meshheading:16921510-JNK Mitogen-Activated Protein Kinases, pubmed-meshheading:16921510-Male, pubmed-meshheading:16921510-Mice, pubmed-meshheading:16921510-Mice, Nude, pubmed-meshheading:16921510-NF-kappa B, pubmed-meshheading:16921510-Neovascularization, Pathologic, pubmed-meshheading:16921510-Nitriles, pubmed-meshheading:16921510-Prostatic Neoplasms, pubmed-meshheading:16921510-Sesquiterpenes, pubmed-meshheading:16921510-TNF Receptor-Associated Factor 1, pubmed-meshheading:16921510-TNF Receptor-Associated Factor 2, pubmed-meshheading:16921510-Taxoids, pubmed-meshheading:16921510-Tosyl Compounds, pubmed-meshheading:16921510-Umbilical Veins, pubmed-meshheading:16921510-Vascular Endothelial Growth Factor A
pubmed:year
2006
pubmed:articleTitle
Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model.
pubmed:affiliation
Department of Medicine, Indiana University, Indianapolis, Indiana, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural